Cell Culture Industry Data Book Covers Cell Culture, Cell Culture Media, 3D Cell Culture, Primary Cell Culture Markets.
Grand View Research’s Cell Culture Industry databook is a collection of market sizing forecasts insights, market dynamics trends, opportunity assessment, regulatory technology framework, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the databook, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.
Cell Culture Market Insights
The global cell culture market size was valued at USD 21.05 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 11.9% from 2022 to 2030.
Media held the largest revenue share of over 50.0% in 2021 due to the high demand for media products for research and development applications. The availability of a variety of serum- and animal-component-free and customized media alternatives has increased the market penetration for media products.
Culture systems dominated the market and accounted for over 25.0% share in 2021. The segment is also expected to register the fastest CAGR over the forecast period due to the development of technologically advanced and automated culturing systems. For instance, in March 2022, CELLINK launched its BIO CELLX bio-dispensing platform for the automation of 3D cell-based assays for drug discovery and cancer research.
The biopharmaceuticals segment held the largest revenue share of over 25.0% in 2021. Due to the involvement of mammalian cell lines, such as the Chinese hamster ovary, in the manufacturing of biopharmaceuticals and the rising demand for non-conventional drugs, biopharmaceutical applications of cell culture techniques are expected to witness growth.
Cell Culture Media Market Insights
The global cell culture media market size was valued at USD 4,075 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 12.23% from 2023 to 2030.
The serum free media segment held the highest share of 35.9% of the market in 2022. The use of SFM signifies a significant tool, which allows the researchers to perform specific application or grow a specific cell type without using serum. Advantages of using SFM include increased growth and/or productivity, more consistent performance, better control over physiological sensitivity, and to diminish the risk of infection by serum-borne adventitious agents in the culture.
The biopharmaceutical production segment dominated the market with a share of 43.11% in 2022. The biopharmaceutical industry’s demand for more reproducible and better-defined media to meet the expanding production levels while reducing the risk of contamination in the downstream processes is significantly increasing the demand for this market.
The liquid media segment captured the highest revenue share of 62.6% in 2022. An increasing number of biologics and biosimilars manufacturers, both downstream and upstream, are switching from premixed powders to liquid media owing to the factors such as rapid mycobacterial growth and high rate of isolation.
The pharma and biopharma companies segment captured the highest revenue share of 34.2% in 2022. The expansion of the current manufacturing capacities for biopharmaceuticals drives the demand for cell culture products.
Access the Global Cell Culture Industry Data Book, 2022 to 2030, compiled with details like market sizing information forecasts, trade data, pricing intelligence, competition benchmarking, macro-environmental analyses, and regulatory technological framework studies
3D Cell Culture Market Insights
The global 3D cell culture market size was valued at USD 1.5 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 10.7% during the forecast period.
Scaffold-based technology accounted for the largest revenue share of over 68.96% in 2020. The use of hydrogels as scaffolds in 3-dimensional cell culture-based research enables the incorporation of sophisticated biochemical and mechanical signs as a mirror of the native extracellular matrix.
The cancer segment dominated the market with the largest revenue share of 24.56% in 2020. The use of spheroids as model systems during the development of anticancer therapies drives RD in this segment. Moreover, the use of 3-dimensional cellular models for the study of cancer biology in preclinical testing and screening is expected to increase revenue generation in this segment.
The biotechnology and pharmaceutical industries segment generated the largest revenue share of over 46% in 2020. 3D cell cultures have advantages in terms of optimal oxygen and nutrient gradients, non-uniform exposure of cells within a spheroid to a drug, and realistic cell-to-cell interactions in comparison to 2D cell culture to study drug candidates. These factors make 3D cell cultures better suited for drug discovery and development, thereby driving the demand.
Primary Cell Culture Market Insights
The global primary cell culture market size was valued at USD 3.4 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.6% from 2021 to 2028.
The reagents and supplements segment dominated the market for primary cell culture and accounted for the largest revenue share of 34.0% in 2020. The growth in the segment is owing to its routine application in research and manufacturing involving primary cell culture. Since primary cells are fragile in nature, the reagents and supplements are considered very crucial for their growth.
The enzymatic degradation segment dominated the market for primary cell culture and accounted for the largest revenue share of 33.3% in 2020. The large share of the segment is owing to its high preference over other techniques for separation of primary cells due to the advantages such as less damage to cultures, comparatively fast, and high yield of a representative sample.
The vaccine production segment dominated the market for primary cell culture and held the largest revenue share of 12.2% in 2020. This growth is owing to the increasing use of primary animal cultures for virus production that is later used for producing several vaccines such as measles, and hepatitis B. In addition, this has also led to cost reduction associated with the use of animal models for vaccine testing.
The animal cells segment dominated the market for primary cell culture and accounted for the largest revenue share of 58.6% in 2020. The growing applications of animal origin primary cells for vaccine development are major factors fueling the segment growth. Animal-derived primary cultures have been used for the development of vaccines against rabies, polio, measles, chickenpox, and hepatitis B.
Cell Culture Market – Global Industry Segmentation
Cell Culture Industry, By Consumables
- Media
- Sera
- Fetal Bovine Serum
- Other Animal Serum
- Reagents
- Albumin
- Other
Cell Culture Industry, By Product
- Culture Systems
- Incubators
- Centrifuges
- Cryostorage Equipment
- Biosafety Equipment
- Pipetting Instruments
Cell Culture Media Industry, By Product
- Serum-free Media
- CHO Media
- BHK Medium
- Vero Medium
- HEK 293 Media
- Other Serum-free media
- Classical Media
- Stem Cell Culture Media
- Specialty Media
- Chemically Defined Media
- Other Cell Culture Media
Cell Culture Media Industry, By Application
- Biopharmaceutical Production
- Monoclonal Antibodies
- Vaccines Production
- Other Therapeutic Proteins
- Diagnostics
- Drug Screening and Development
- Tissue Engineering and Regenerative Medicine
- Cell and Gene Therapy
- Other tissue engineering and regenerative medicine applications
- Other Applications
Cell Culture Media Industry, By Type
- Liquid Media
- Semi-solid and Solid Media
Cell Culture Media Industry, By End user
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Laboratories
- Research and Academic Institutes
- Others
3D Cell Culture Industry, By Technology
- Scaffold based
- Hydrogels
- Polymeric scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold free
- Hanging drop microplates
- Spheroid microplates containing Ultra-Low Attachment (ULA) coating
- Microfluidic 3D cell culture
- Magnetic levitations 3D bioprinting
- 3D Bioreactors
3D Cell Culture Industry, By Application
- Cancer
- Tissue engineering Immunohistochemistry
- Drug development
- Stem cell research
- Others
3D Cell Culture Industry, By End use
- Biotechnology and pharmaceutical industries
- Research laboratories and institutes
- Hospitals and diagnostic centers
- Others
Primary Cell Culture Industry, By Product
- Primary Cells
- Fat Cells
- Blood Cells
- Nerve Cells
- Bone Cells
- Endothelial Cells
- Skin Cells
- Muscle Cells
- Stem Cells
- Others
- Reagents and Supplements
- Attachment Solutions
- Buffers and Salts
- Freezing Media
- Sera
- Growth Factors and Cytokines
- Others
- Media
Primary Cell Culture Industry, By Separation Methods
- Explant Method
- Enzymatic Degradation
- Trypsin
- Collagenase
- Protease
- Pronase
- Dispase
- Hyaluronidase
- Neuraminidase
- Elastase
- DNase
- Papain
- Accutase
- Others
- Mechanical Separation
- Others
Primary Cell Culture Industry, By Cell Type
- Animal Cells
- Human Cells
Primary Cell Culture Industry, By Application
- Tissue Culture Tissue Engineering
- Vaccine Production
- Gene Therapy and Regenerative Medicine
- Toxicity Testing and Drug Screening
- Cancer Research
- Model System
- Virology
- Prenatal Diagnosis
- Stem Cell Therapy
- Others
Order your copy of the Free Sample of “Cell Culture Industry Data Book - Cell Culture, Cell Culture Media, 3D Cell Culture, Primary Cell Culture Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research
Cell Culture Industry Data Book Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East Africa (MEA)
- South Africa
- United Arab Emirates
- Saudi Arabia
- Rest of Middle East Africa
Cell Culture Industry Data Book Competitive Landscape
Competitive rivalry in the cell culture industry is high due to the presence of a large number of both well-established players and small- to mid-sized companies as well as CROs in the market space.
Key players operating in the cell culture industry are –
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Eppendorf AG
- Merck KGaA
- Becton
- Dickinson and Company
- PromoCell GmbH
- Lonza Group AG
Go through the table of content of Cell Culture Industry Data Book to get a better understanding of the Coverage Scope of the study
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com/sector-reports-list
